Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 13-Nov-23 2:40 PM View:  | Intercept Pharmaceuticals, ... (ICPT) | 08-Nov-23 | Disposition (change in control) | 618,894 | $19.00 | $11,759,000.00 | (100%) 618.89K to 0 | |
| 02-Dec-21 4:05 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 30-Nov-21 | Grant | 6,138 | $17.21 | $105,635.00 | < 1% 616.57K to 622.71K | (8%) |
| 02-Dec-21 4:05 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 30-Nov-21 | Payment of Exercise | 3,817 | $17.21 | $65,690.60 | (< 1%) 622.71K to 618.89K | 8% |
| 02-Nov-21 4:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 29-Oct-21 | Grant | 6,138 | $16.86 | $103,487.00 | < 1% 614.25K to 620.39K | 2% |
| 02-Nov-21 4:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 29-Oct-21 | Payment of Exercise | 3,817 | $16.86 | $64,354.60 | (< 1%) 620.39K to 616.57K | (2%) |
| 04-Oct-21 5:02 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 30-Sep-21 | Grant | 6,136 | $14.85 | $91,119.60 | 1% 611.93K to 618.07K | 2% |
| 04-Oct-21 5:02 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 30-Sep-21 | Payment of Exercise | 3,816 | $14.85 | $56,667.60 | (< 1%) 618.07K to 614.25K | (2%) |
| 01-Sep-21 7:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 31-Aug-21 | Grant | 6,138 | $14.91 | $91,517.60 | 1% 609.61K to 615.75K | 0% |
| 01-Sep-21 7:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 31-Aug-21 | Payment of Exercise | 3,817 | $14.91 | $56,911.50 | (< 1%) 615.75K to 611.93K | 0% |
| 02-Aug-21 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 30-Jul-21 | Grant | 6,138 | $17.28 | $106,065.00 | 1% 607.29K to 613.43K | (< 1%) |
| 02-Aug-21 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 30-Jul-21 | Payment of Exercise | 3,817 | $17.28 | $65,957.80 | (< 1%) 613.43K to 609.61K | < 1% |
| 01-Jul-21 7:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 30-Jun-21 | Grant | 6,136 | $19.97 | $122,536.00 | 1% 604.97K to 611.11K | < 1% |
| 01-Jul-21 7:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 30-Jun-21 | Payment of Exercise | 3,816 | $19.97 | $76,205.50 | (< 1%) 611.11K to 607.29K | (< 1%) |
| 02-Jun-21 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 28-May-21 | Grant | 6,138 | $16.63 | $102,075.00 | 1% 602.65K to 608.79K | 3% |
| 02-Jun-21 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 28-May-21 | Payment of Exercise | 3,817 | $16.63 | $63,476.70 | (< 1%) 608.79K to 604.97K | (3%) |
| 04-May-21 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 30-Apr-21 | Grant | 6,138 | $19.78 | $121,410.00 | 1% 600.33K to 606.47K | < 1% |
| 04-May-21 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 30-Apr-21 | Payment of Exercise | 3,817 | $19.78 | $75,500.30 | (< 1%) 606.47K to 602.65K | (< 1%) |
| 01-Apr-21 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 31-Mar-21 | Grant | 6,136 | $23.08 | $141,619.00 | 1% 597.85K to 603.99K | 0% |
| 01-Apr-21 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 31-Mar-21 | Payment of Exercise | 3,658 | $23.08 | $84,426.60 | (< 1%) 603.99K to 600.33K | 0% |
| 02-Mar-21 7:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 26-Feb-21 | Grant | 6,138 | $21.66 | $132,949.00 | 1% 594.45K to 600.59K | < 1% |
| 02-Mar-21 7:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 26-Feb-21 | Payment of Exercise | 2,741 | $21.66 | $59,370.10 | (< 1%) 600.59K to 597.85K | (< 1%) |
| 02-Feb-21 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 29-Jan-21 | Grant | 6,138 | $35.24 | $216,303.00 | 1% 591.06K to 597.19K | 5% |
| 02-Feb-21 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 29-Jan-21 | Payment of Exercise | 2,741 | $35.24 | $96,592.80 | (< 1%) 597.19K to 594.45K | (5%) |
| 05-Jan-21 7:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 01-Jan-21 | Payment of Exercise | 632 | $24.70 | $15,610.40 | (< 1%) 591.69K to 591.06K | (26%) |
| 05-Jan-21 7:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 31-Dec-20 | Grant | 41,236 | $24.70 | $1,018,530.00 | 7% 575.52K to 616.75K | 26% |
| 05-Jan-21 7:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 31-Dec-20 | Payment of Exercise | 25,065 | $24.70 | $619,106.00 | (4%) 616.75K to 591.69K | (26%) |
| 05-Oct-20 7:01 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 01-Oct-20 | Payment of Exercise | 772 | $42.08 | $32,485.80 | (< 1%) 576.29K to 575.52K | 36% |
| 06-Jul-20 7:02 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 01-Jul-20 | Payment of Exercise | 772 | $46.52 | $35,913.40 | (< 1%) 577.06K to 576.29K | 42% |
| 03-Apr-20 7:06 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 01-Apr-20 | Payment of Exercise | 568 | $58.40 | $33,171.20 | (< 1%) 577.63K to 577.06K | 54% |
| 27-Jan-20 7:07 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 23-Jan-20 | Grant | 10,800 | -- | -- | 2% 566.83K to 577.63K | |
| 03-Jan-20 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 01-Jan-20 | Payment of Exercise | 1,166 | $123.92 | $144,491.00 | (< 1%) 568.0K to 566.83K | 78% |
| 03-Jan-20 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 31-Dec-19 | Payment of Exercise | 1,131 | $123.92 | $140,154.00 | (< 1%) 569.23K to 568.1K | 78% |
| 03-Jan-20 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 31-Dec-19 | Option Exercise | 100 | $21.50 | $2,150.00 | < 1% 569.13K to 569.23K | |
| 03-Jan-20 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 31-Dec-19 | Market Option Sale (Planned) | 100 | $125.00 | $12,500.00 | (< 1%) 568.1K to 568.0K | 79% |
| 30-Dec-19 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 26-Dec-19 | Option Exercise | 417 | $21.50 | $8,965.50 | < 1% 569.13K to 569.54K | |
| 30-Dec-19 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 26-Dec-19 | Market Option Sale (Planned) | 417 | $125.00 | $52,125.00 | (< 1%) 569.54K to 569.13K | 79% |
| 27-Nov-19 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 26-Nov-19 | Option Exercise | 35,437 | $14.30 | $506,770.00 | 6% 569.13K to 604.56K | |
| 27-Nov-19 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 26-Nov-19 | Market Option Sale (Planned) | 35,437 | $100.00 | $3,543,700.00 | (6%) 604.56K to 569.13K | 73% |
| 27-Nov-19 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 25-Nov-19 | Option Exercise | 14,563 | $8.67 | $126,213.00 | 3% 569.13K to 583.69K | |
| 27-Nov-19 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 25-Nov-19 | Market Option Sale (Planned) | 14,563 | $100.00 | $1,456,300.00 | (2%) 583.69K to 569.13K | 73% |
| 03-Oct-19 7:02 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 01-Oct-19 | Payment of Exercise | 1,547 | $65.87 | $101,901.00 | (< 1%) 570.67K to 569.13K | 59% |
| 03-Jul-19 5:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 01-Jul-19 | Payment of Exercise | 1,548 | $79.17 | $122,555.00 | (< 1%) 572.22K to 570.67K | 66% |
| 03-Apr-19 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 01-Apr-19 | Payment of Exercise | 1,547 | $111.50 | $172,490.00 | (< 1%) 573.77K to 572.22K | 76% |
| 18-Jan-19 7:03 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 16-Jan-19 | Grant | 8,500 | -- | -- | 2% 565.27K to 573.77K | |
| 03-Jan-19 7:03 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 01-Jan-19 | Payment of Exercise | 1,537 | $100.79 | $154,914.00 | (< 1%) 566.8K to 565.27K | 73% |
| 16-Nov-18 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 16-Nov-18 | Option Exercise | 27,606 | $8.67 | $239,253.00 | 5% 566.8K to 594.41K | |
| 16-Nov-18 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 16-Nov-18 | Market Option Sale (Planned) | 27,606 | $101.54 | $2,803,130.00 | (5%) 594.41K to 566.8K | 74% |
| 16-Nov-18 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 15-Nov-18 | Option Exercise | 22,394 | $8.67 | $194,082.00 | 4% 566.8K to 589.2K | |
| 16-Nov-18 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 15-Nov-18 | Market Option Sale (Planned) | 22,394 | $100.50 | $2,250,580.00 | (4%) 589.2K to 566.8K | 73% |
| 03-Oct-18 7:00 PM View: | Intercept Pharmaceuticals, ... (ICPT) | 01-Oct-18 | Payment of Exercise | 2,049 | $126.46 | $259,117.00 | (< 1%) 568.85K to 566.8K | 79% |